← Every company
BioMarin Pharmaceutical Inc SEC Filings
What BioMarin Pharmaceutical Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
BMRN overview →Filings on file
139
since Oct 27, 2016
Warning signs
0
none filed
Last results
Oct 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Oct 6, 2026 | Results announced 8-K | Read ↗ |
| Sep 30, 2026 | Material agreement 8-K | Read ↗ |
| Sep 14, 2026 | Executive or director change 8-K | Read ↗ |
| Aug 31, 2026 | Material agreement 8-K | Read ↗ |
| Aug 18, 2026 | Material agreement 8-K | Read ↗ |
| Aug 6, 2026 | Quarterly report 10-Q | Read ↗ |
| Aug 6, 2026 | Results announced 8-K | Read ↗ |
| Jun 4, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 5, 2026 | Quarterly report 10-Q | Read ↗ |
| May 4, 2026 | Results announced 8-K | Read ↗ |
| Apr 27, 2026 | Acquisition or sale completedMaterial agreementNew debt 8-K | Read ↗ |
| Feb 26, 2026 | Annual report 10-K | Read ↗ |
| Feb 23, 2026 | Results announced 8-K | Read ↗ |
| Feb 12, 2026 | Material agreementNew debt 8-K | Read ↗ |
| Jan 26, 2026 | Results announced 8-K | Read ↗ |
| Jan 12, 2026 | Results announced 8-K | Read ↗ |
| Dec 19, 2025 | Material agreement 8-K | Read ↗ |
| Dec 17, 2025 | Executive or director change 8-K | Read ↗ |
| Oct 28, 2025 | Quarterly report 10-Q | Read ↗ |
| Oct 27, 2025 | Results announced 8-K | Read ↗ |
| Oct 7, 2025 | Results announced 8-K | Read ↗ |
| Aug 11, 2025 | Executive or director change 8-K | Read ↗ |
| Aug 5, 2025 | Quarterly report 10-Q | Read ↗ |
| Aug 4, 2025 | Results announced 8-K | Read ↗ |
| Aug 1, 2025 | Executive or director change 8-K | Read ↗ |
| Jun 2, 2025 | Tender offer SC TO-T | Read ↗ |
| May 22, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 16, 2025 | Material agreement 8-K | Read ↗ |
| May 2, 2025 | Quarterly report 10-Q | Read ↗ |
| May 1, 2025 | Results announced 8-K | Read ↗ |
| Feb 24, 2025 | Executive or director change 8-K | Read ↗ |
| Feb 24, 2025 | Annual report 10-K | Read ↗ |
| Feb 19, 2025 | Results announced 8-K | Read ↗ |
| Oct 31, 2024 | Quarterly report 10-Q | Read ↗ |
| Oct 29, 2024 | Results announced 8-K | Read ↗ |
| Sep 4, 2024 | Material agreementNew debt 8-K | Read ↗ |
| Aug 28, 2024 | Restructuring 8-K | Read ↗ |
| Aug 22, 2024 | Executive or director change 8-K | Read ↗ |
| Aug 5, 2024 | Quarterly report 10-Q | Read ↗ |
| Aug 5, 2024 | Results announced 8-K | Read ↗ |
| May 24, 2024 | Shareholder vote 8-K | Read ↗ |
| May 14, 2024 | Restructuring 8-K | Read ↗ |
| Apr 26, 2024 | Quarterly report 10-Q | Read ↗ |
| Apr 24, 2024 | Results announced 8-K | Read ↗ |
| Feb 26, 2024 | Annual report 10-K | Read ↗ |
| Feb 22, 2024 | Results announced 8-K | Read ↗ |
| Jan 11, 2024 | Executive or director change 8-K | Read ↗ |
| Dec 20, 2023 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| Nov 3, 2023 | Executive or director change 8-K | Read ↗ |
| Nov 2, 2023 | Quarterly report 10-Q | Read ↗ |
| Nov 1, 2023 | Results announced 8-K | Read ↗ |
| Aug 2, 2023 | Quarterly report 10-Q | Read ↗ |
| Jul 31, 2023 | Results announced 8-K | Read ↗ |
| May 30, 2023 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 28, 2023 | Quarterly report 10-Q | Read ↗ |
| Apr 26, 2023 | Results announced 8-K | Read ↗ |
| Feb 27, 2023 | Annual report 10-K | Read ↗ |
| Feb 27, 2023 | Results announced 8-K | Read ↗ |
| Jan 11, 2023 | Results announced 8-K | Read ↗ |
| Oct 28, 2022 | Quarterly report 10-Q | Read ↗ |
| Oct 26, 2022 | Results announced 8-K | Read ↗ |
| Oct 7, 2022 | Restructuring 8-K | Read ↗ |
| Aug 4, 2022 | Quarterly report 10-Q | Read ↗ |
| Aug 3, 2022 | Results announced 8-K | Read ↗ |
| May 31, 2022 | Shareholder vote 8-K | Read ↗ |
| May 5, 2022 | Executive or director change 8-K | Read ↗ |
| Apr 29, 2022 | Quarterly report 10-Q | Read ↗ |
| Apr 27, 2022 | Results announced 8-K | Read ↗ |
| Feb 25, 2022 | Annual report 10-K | Read ↗ |
| Feb 23, 2022 | Results announced 8-K | Read ↗ |
| Feb 14, 2022 | Material agreement 8-K | Read ↗ |
| Dec 15, 2021 | Executive or director change 8-K | Read ↗ |
| Nov 3, 2021 | Executive or director change 8-K | Read ↗ |
| Oct 29, 2021 | Quarterly report 10-Q | Read ↗ |
| Oct 27, 2021 | Results announced 8-K | Read ↗ |
| Jul 30, 2021 | Quarterly report 10-Q | Read ↗ |
| Jul 28, 2021 | Results announced 8-K | Read ↗ |
| Jun 2, 2021 | Material agreementNew debt 8-K | Read ↗ |
| Jun 1, 2021 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 30, 2021 | Quarterly report 10-Q | Read ↗ |
| Apr 29, 2021 | Results announced 8-K | Read ↗ |
| Feb 26, 2021 | Annual report 10-K | Read ↗ |
| Feb 25, 2021 | Results announced 8-K | Read ↗ |
| Feb 22, 2021 | Executive or director change 8-K | Read ↗ |
| Nov 6, 2020 | Quarterly report 10-Q | Read ↗ |
| Nov 5, 2020 | Results announced 8-K | Read ↗ |
| Aug 5, 2020 | Quarterly report 10-Q | Read ↗ |
| Aug 4, 2020 | Results announced 8-K | Read ↗ |
| Jul 2, 2020 | Executive or director change 8-K | Read ↗ |
| Jun 1, 2020 | Shareholder vote 8-K | Read ↗ |
| May 19, 2020 | New debtUnregistered share sale 8-K | Read ↗ |
| May 14, 2020 | Material agreementNew debtUnregistered share sale 8-K | Read ↗ |
| May 1, 2020 | Quarterly report 10-Q | Read ↗ |
| Apr 29, 2020 | Results announced 8-K | Read ↗ |
| Apr 22, 2020 | Executive or director change 8-K | Read ↗ |
| Feb 27, 2020 | Annual report 10-K | Read ↗ |
| Feb 26, 2020 | Results announced 8-K | Read ↗ |
| Feb 3, 2020 | Executive or director change 8-K | Read ↗ |
| Nov 4, 2019 | Quarterly report 10-Q/A | Read ↗ |
| Oct 29, 2019 | Quarterly report 10-Q | Read ↗ |
| Oct 23, 2019 | Results announced 8-K | Read ↗ |
| Aug 2, 2019 | Quarterly report 10-Q | Read ↗ |
| Aug 1, 2019 | Results announced 8-K | Read ↗ |
| Jul 10, 2019 | Executive or director change 8-K | Read ↗ |
| Jun 7, 2019 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 29, 2019 | Quarterly report 10-Q | Read ↗ |
| Apr 25, 2019 | Results announced 8-K | Read ↗ |
| Feb 28, 2019 | Annual report 10-K | Read ↗ |
| Feb 21, 2019 | Results announced 8-K | Read ↗ |
| Jan 8, 2019 | Results announced 8-K | Read ↗ |
| Oct 26, 2018 | Quarterly report 10-Q | Read ↗ |
| Oct 25, 2018 | Results announced 8-K | Read ↗ |
| Oct 23, 2018 | Material agreementNew debt 8-K | Read ↗ |
| Aug 3, 2018 | Quarterly report 10-Q | Read ↗ |
| Aug 2, 2018 | Results announced 8-K | Read ↗ |
| Jun 8, 2018 | Shareholder vote 8-K | Read ↗ |
| Apr 27, 2018 | Quarterly report 10-Q | Read ↗ |
| Apr 25, 2018 | Results announced 8-K | Read ↗ |
| Feb 26, 2018 | Annual report 10-K | Read ↗ |
| Feb 22, 2018 | Results announced 8-K | Read ↗ |
| Nov 28, 2017 | Material agreement 8-K | Read ↗ |
| Nov 13, 2017 | Quarterly report 10-Q/A | Read ↗ |
| Oct 31, 2017 | Quarterly report 10-Q | Read ↗ |
| Oct 26, 2017 | Results announced 8-K | Read ↗ |
| Oct 3, 2017 | Executive or director change 8-K | Read ↗ |
| Aug 11, 2017 | Material agreementNew debt 8-K | Read ↗ |
| Aug 2, 2017 | Quarterly report 10-Q | Read ↗ |
| Aug 2, 2017 | Results announced 8-K | Read ↗ |
| Jun 12, 2017 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 4, 2017 | Quarterly report 10-Q | Read ↗ |
| May 4, 2017 | Results announced 8-K | Read ↗ |
| Apr 13, 2017 | Material agreement 8-K | Read ↗ |
| Feb 27, 2017 | Annual report 10-K | Read ↗ |
| Feb 23, 2017 | Results announced 8-K | Read ↗ |
| Dec 19, 2016 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| Dec 9, 2016 | Executive or director change 8-K | Read ↗ |
| Dec 2, 2016 | Material agreementNew debt 8-K | Read ↗ |
| Nov 3, 2016 | Quarterly report 10-Q | Read ↗ |
| Oct 27, 2016 | Results announced 8-K | Read ↗ |
Source: BioMarin Pharmaceutical Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on BMRN
Company overviewEverything on BMRN in one place, with the price.Insider tradingWhat BMRN's own officers and directors buy and sell.Executive payWhat BMRN awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in BMRN.Funds holding itWhich funds and ETFs hold BMRN, and how big a bet.LobbyingWhat BMRN spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on BMRN's account, and who they worked for.PatentsWhat BMRN is filing at the patent office.